Australian scientists unveil "pain-on-a-chip" to identify pain types
(MENAFN) Australian scientists have unveiled a groundbreaking "pain-on-a-chip" technology capable of differentiating between different types of chronic pain, providing promising advancements for improved diagnosis and treatment, according to a report from Monash University on Monday.
This cutting-edge biosensor is minimally invasive and employs live sensory nerves, known as nociceptors, to precisely detect pain biomarkers from blood samples. The device has effectively distinguished between two animal models of chronic pain: fibromyalgia as well as diabetic neuropathy, as outlined in a study conducted in collaboration with Flinders University.
Chronic pain is a prevalent concern that poses considerable difficulties in management, primarily due to the reliance on patients' subjective reports in existing clinical practices. This reliance can create particular challenges for non-verbal patients, as highlighted by a statement from Monash University regarding research featured in Biosensors and Bioelectronics.
"Improving pain classification and identifying new treatments requires new strategies that objectively recognize specific pain conditions and minimize subjectivity," remarked Nicolas Voelcker from the Monash Institute of Pharmaceutical Sciences, a lead author of the study.
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
